• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up0.25% Nasdaq Up0.65%

    InVivo Therapeutics Holdings Corp. (NVIV)

    -NasdaqGM
    6.68 Up 0.28(4.37%) May 27, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
    Total Revenue -   -   -  
    Cost of Revenue -   -   -  
    Gross Profit -   -   -  
    Operating Expenses
    Research Development10,058  10,273  10,533  
    Selling General and Administrative12,340  7,566  8,472  
    Non Recurring -   -   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss (22,398) (17,839) (19,005)
    Income from Continuing Operations
    Total Other Income/Expenses Net(10,744)(371)(19,621)
    Earnings Before Interest And Taxes(33,142)(18,210)(38,626)
    Interest Expense172  136  130  
    Income Before Tax(33,314)(18,346)(38,756)
    Income Tax Expense -   -   -  
    Minority Interest -   -   -  
    Net Income From Continuing Ops(33,314)(18,346)(38,756)
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income (33,314) (18,346) (38,756)
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares (33,314) (18,346) (38,756)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.